"Gene Rearrangement" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The ordered rearrangement of gene regions by DNA recombination such as that which occurs normally during development.
Descriptor ID |
D015321
|
MeSH Number(s) |
G05.344
|
Concept/Terms |
Gene Rearrangement- Gene Rearrangement
- Gene Rearrangements
- Rearrangement, Gene
- Rearrangements, Gene
- DNA Rearrangement
- DNA Rearrangements
- Rearrangement, DNA
- Rearrangements, DNA
|
Below are MeSH descriptors whose meaning is more general than "Gene Rearrangement".
Below are MeSH descriptors whose meaning is more specific than "Gene Rearrangement".
This graph shows the total number of publications written about "Gene Rearrangement" by people in this website by year, and whether "Gene Rearrangement" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 2 | 2 | 4 |
1995 | 2 | 3 | 5 |
1996 | 1 | 7 | 8 |
1997 | 2 | 3 | 5 |
1998 | 2 | 6 | 8 |
1999 | 3 | 6 | 9 |
2000 | 1 | 3 | 4 |
2001 | 2 | 2 | 4 |
2002 | 4 | 4 | 8 |
2003 | 1 | 4 | 5 |
2004 | 1 | 4 | 5 |
2005 | 3 | 6 | 9 |
2006 | 5 | 4 | 9 |
2007 | 4 | 6 | 10 |
2008 | 8 | 3 | 11 |
2009 | 9 | 9 | 18 |
2010 | 7 | 6 | 13 |
2011 | 9 | 8 | 17 |
2012 | 15 | 11 | 26 |
2013 | 3 | 8 | 11 |
2014 | 3 | 6 | 9 |
2015 | 4 | 16 | 20 |
2016 | 4 | 9 | 13 |
2017 | 3 | 14 | 17 |
2018 | 5 | 5 | 10 |
2019 | 10 | 8 | 18 |
2020 | 6 | 9 | 15 |
2021 | 5 | 11 | 16 |
2022 | 0 | 7 | 7 |
2023 | 1 | 5 | 6 |
2024 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Gene Rearrangement" by people in Profiles.
-
Circulating Tumor DNA Enables Sensitive Detection of Actionable Gene Fusions and Rearrangements Across Cancer Types. Clin Cancer Res. 2024 02 16; 30(4):836-848.
-
Myeloid lineage switch in KMT2A-rearranged acute lymphoblastic leukemia treated with lymphoid lineagedirected therapies. Haematologica. 2024 Jan 01; 109(1):293-297.
-
The Clinicopathologic Features and Molecular Signatures of Blastoid High-Grade B Cell Lymphoma, Not Otherwise Specified. Mod Pathol. 2023 Dec; 36(12):100349.
-
Detection of clinically actionable gene fusions by next-generation sequencing-based RNA sequencing of non-small cell lung cancer cytology specimens: A single-center experience with comparison to fluorescence in?situ hybridization. Cancer Cytopathol. 2024 Jan; 132(1):41-49.
-
Follicular lymphoma and diffuse large B-cell lymphoma with BCL2 and IRF4 rearrangements in adult patients. Hum Pathol. 2023 Nov; 141:22-29.
-
A Molecular Blueprint to Targeting ALK Gene Fusions in Glioblastoma. Clin Cancer Res. 2023 07 14; 29(14):2567-2569.
-
Philadelphia-Like Genetic Rearrangements in Adults With B-Cell ALL: Refractoriness to Chemotherapy and Response to Tyrosine Kinase Inhibitor in ABL Class Rearrangements. JCO Precis Oncol. 2023 05; 7:e2200707.
-
Intratumoral Heterogeneity and Clonal Evolution Induced by HPV Integration. Cancer Discov. 2023 04 03; 13(4):910-927.
-
Early mortality in acute myeloid leukemia with KMT2A rearrangement is associated with high risk of bleeding and disseminated intravascular coagulation. Cancer. 2023 06 15; 129(12):1856-1865.
-
Clinical impact of 5'MYC or 3'MYC gain/loss detected by FISH in patients with aggressive B-cell lymphomas. Cancer Genet. 2023 04; 272-273:1-8.